Indoleamine 2,3-dioxygenase (IDO) in inflammation and allergy to Aspergillus

Medical Mycology

Volumn 47, Issue SUPPL. 1, 2009, Pages

  Romani, Luigina ^a   Zelante, Teresa ^a   de Luca, Antonella ^a   Bozza, Silvia ^a   Bonifazi, Pierluigi ^a   Moretti, Silvia ^a   D'Angelo, Carmen ^a   Giovannini, Gloria ^a   Bistoni, Francesco ^a   Fallarino, Francesca ^a   Puccetti, Paolo ^a  

^a Fondazione Istituto di Ricovero e Cura per le Biotecnologie Trapiantologiche   (Italy)

Author keywords

Aspergillus; Indoleamine 2,3 dioxygenase; Inflammation; Regulatory T cells; Th17 cells

Indexed keywords

B7 ANTIGEN; BETA GLUCAN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DECTIN 1; DECTIN 2; GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 23; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELOID DIFFERENTIATION FACTOR 88; PROTEINASE ACTIVATED RECEPTOR; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA; TRYPTOPHAN; TRYPTOPHAN 2,3 DIOXYGENASE;

ADAPTIVE IMMUNITY; ALLERGY; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIDULANS; CONIDIUM; CYTOKINE PRODUCTION; HUMAN; IMMUNOREGULATION; INFECTION; INNATE IMMUNITY; METABOLIC REGULATION; MYCOSIS; NONHUMAN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; TH1 CELL; TH17 CELL; TH2 CELL; HOST PATHOGEN INTERACTION; HYPERSENSITIVITY; IMMUNOLOGY; INFLAMMATION; PATHOLOGY; REVIEW; T LYMPHOCYTE SUBPOPULATION;

ASPERGILLUS; ASPERGILLUS FUMIGATUS; FUNGI;

ASPERGILLUS FUMIGATUS; HOST-PATHOGEN INTERACTIONS; HUMANS; HYPERSENSITIVITY; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INFLAMMATION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 67651085705     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780802139867     Document Type: Article

References (68)

1. Latge JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 1999; 12: 310-350.
2. Marr KA, Patterson T, Denning D. Aspergillosis. Pathogenesis, clinical manifestations, and therapy. Infect Dis Clin North Am 2002; 16 875-894, vi.
3. Stergiopoulou T, Meletiadis J, Roilides E, et al. Host-dependent patterns of tissue injury in invasive pulmonary aspergillosis. Am J Clin Pathol 2007; 127: 349-355.
4. Hoebe K, Janssen E, Beutler B. The interface between innate and adaptive immunity. Nat Immunol 2004; 5: 971-974.
5. Trinchieri G, Sher A. Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol 2007; 7: 179-190.
6. Gersuk GM, Underhill DM, Zhu L, Marr KA. Dectin-1 and TLRs permit macrophages to distinguish between different Aspergillus fumigatus cellular states. J Immunol 2006; 176: 3717-3724.
7. Hohl TM, Van Epps HL, Rivera A, et al. Aspergillus fumigatus triggers inflammatory responses by stage-specific beta-glucan display. PLoS Pathog 2005; 1: E30.
8. Steele C, Rapaka RR, Metz A, et al. The beta-glucan receptor dectin-1 recognizes specific morphologies of Aspergillus fumigatus PLoS Pathog 2005; 1: E42.
9. Bignell E, Negrete-Urtasun S, Calcagno AM, et al. Virulence comparisons of Aspergillus nidulans mutants are confounded by the inflammatory response of p47phox-/-mice. Infect Immun 2005; 73 5204-5207.
10. Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore) 2000; 79: 170-200.
11. Romani L, Fallarino F, De Luca A, et al. Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature 2008; 451: 211-215.
12. Miceli MH, Maertens J, Buve K, et al. Immune reconstitution inflammatory syndrome in cancer patients with pulmonary aspergillosis recovering from neutropenia: Proof of principle, description, and clinical and research implications. Cancer 2007; 110: 112-120.
13. Shelburne SA, 3rd, Darcourt J, White Acm, Jr, et al. The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy. Clin Infect Dis 2005; 40: 1049-1052.
14. Singh N, Perfect JR. Immune reconstitution syndrome associated with opportunistic mycoses. Lancet Infect Dis 2007; 7: 395-401.
15. Ortega M, Rovira M, Filella X, et al. Prospective evaluation of procalcitonin in adults with non-neutropenic fever after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2006; 37: 499-502.
16. Schubert MS. Allergic fungal sinusitis. Clin Rev Allergy Immunol 2006; 30: 205-216.
17. Romani L, Puccetti P. Controlling pathogenic inflammation to fungi. Expert Rev Anti Infect Ther 2007; 5: 1007-1017.
18. Gutcher I, Becher B. APC-derived cytokines and T cell polarization in autoimmune inflammation. J Clin Invest 2007; 117: 1119-1127.
19. Langrish CL, McKenzie BS, Wilson NJ, et al. IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol Rev 2004; 202: 96-105.
20. Montagnoli C, Fallarino F, Gaziano R, et al. Immunity and tolerance to Aspergillus involve functionally distinct regulatory T cells and tryptophan catabolism. J Immunol 2006; 176: 1712-1723.
21. Romani L, Puccetti P. Protective tolerance to fungi: The role of IL-10 and tryptophan catabolism. Trends Microbiol 2006; 14: 183-189.
22. Zelante T, De Luca A, Bonifazi P, et al. IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol 2007; 37: 2695-2706.
23. Linden A, Laan M, Anderson GP. Neutrophils, interleukin-17A and lung disease. Eur Respir J 2005; 25: 159-172.
24. Smith E, Zarbock A, Stark MA, et al. IL-23 is required for neutrophil homeostasis in normal and neutrophilic mice. J Immunol 2007; 179: 8274-8279.
25. Bozza S, Fallarino F, Pitzurra L, et al. A crucial role for tryptophan catabolism at the host/Candida albicans interface. J Immunol 2005; 174: 2910-2918.
26. Romani L, Zelante T, De Luca A, Fallarino F, Puccetti P. IL-17 and therapeutic kynurenines in pathogenic inflammation to fungi. J Immunol 2008; 180: 1557-5162.
27. Fallarino F, Grohmann U, Hwang KW, et al. Modulation of tryptophan catabolism by regulatory T cells. Nat Immunol 2003; 4: 1206-1212.
28. Grohmann U, Fallarino F, Puccetti P. Tolerance, DCs and tryptophan: Much ado about IDO. Trends Immunol 2003; 24: 242-248.
29. Grohmann U, Volpi C, Fallarino F, et al. Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy. Nat Med 2007; 13: 579-586.
30. Mellor AL, Munn DH. IDO expression by dendritic cells: Tolerance and tryptophan catabolism. Nat Rev Immunol 2004; 4: 762-774.
31. Puccetti P, Grohmann U. IDO and regulatory T cells: A role for reverse signalling and non-canonical NF-kappaB activation. Nat Rev Immunol 2007; 7: 817-823.
32. MacKenzie CR, Heseler K, Muller A, Daubener W. Role of indoleamine 2,3-dioxygenase in antimicrobial defence and immuno-regulation: tryptophan depletion versus production of toxic kynurenines. Curr Drug Metab 2007; 8: 237-244.
33. Katz JB, Muller AJ, Prendergast GC. Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape. Immunol Rev 2008; 222: 206-221.
34. Romani L. Immunity to fungal infections. Nat Rev Immunol 2004; 4: 1-23.
35. Antachopoulos C, Walsh TJ, Roilides E. Fungal infections in primary immunodeficiencies. Eur J Pediatr 2007; 166: 1099-1117.
36. Freeman AF, Kleiner DE, Nadiminti H, et al. Causes of death in hyper-IgE syndrome. J Allergy Clin Immunol 2007; 119: 1234-1240.
37. Sambatakou H, Pravica V, Hutchinson IV, Denning DW. Cytokine profiling of pulmonary aspergillosis. Int J Immunogenet 2006; 33: 297-302.
38. Romani L, Bistoni F, Perruccio K, et al. Thymosin alpha1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and tolerance. Blood 2006; 108: 2265-2274.
39. Hayashi T, Beck L, Rossetto C, et al. Inhibition of experimental asthma by indoleamine 2,3-dioxygenase. J Clin Invest 2004; 114 270-279.
40. von Bubnoff D, Fimmers R, Bogdanow M, et al. Asymptomatic atopy is associated with increased indoleamine 2,3-dioxygenase activity and interleukin-10 production during seasonal allergen exposure. Clin Exp Allergy 2004; 34: 1056-1063.
41. Kwidzinski E, Bunse J, Aktas O, et al. Indolamine 2,3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation. Faseb J 2005; 19: 1347-1349.
42. Wills-Karp M, Santeliz J, Karp CL. The germless theory of allergic disease: Revisiting the hygiene hypothesis. Nat Rev Immunol 2001; 1: 69-75.
43. Denning DW, O'Driscoll BR, Hogaboam CM, Bowyer P, Niven RM. The link between fungi and severe asthma: A summary of the evidence. Eur Respir J 2006; 27: 615-626.
44. Judson MA, Stevens DA. Current pharmacotherapy of allergic bronchopulmonary aspergillosis. Expert Opin Pharmacother 2001; 2: 1065-1071.
45. Bellocchio S, Moretti S, Perruccio K, et al. TLRs govern neutrophil activity in aspergillosis. J Immunol 2004; 173: 7406-7415.
46. Braedel S, Radsak M, Einsele H, et al. Aspergillus fumigatus antigens activate innate immune cells via toll-like receptors 2 and 4. Br J Haematol 2004; 125: 392-399.
47. Bretz C, Gersuk G, Knoblaugh S, et al. Myd88-Signaling contributes to early pulmonary responses to Aspergillus fumigatus. Infect Immun 2008; 76: 952-958.
48. Chignard M, Balloy V, Sallenave JM, Si-Tahar M. Role of Tolllike receptors in lung innate defense against invasive aspergillosis. Distinct impact in immunocompetent and immunocompromized hosts. Clin Immunol 2007; 124: 238-243.
49. Mambula SS, Sau K, Henneke P, Golenbock DT, Levitz SM. Tolllike receptor (TLR) signaling in response to Aspergillus fumigatus. J Biol Chem 2002; 277: 39320-39326.
50. Netea MG, Warris A, Van der Meer JW, et al. Aspergillus fumigatus evades immune recognition during germination through loss of toll-like receptor-4-mediated signal transduction. J Infect Dis 2003; 188 320-326.
51. Rivera A, Ro G, Van Epps HL, et al. Innate immune activation and CD4+ T cell priming during respiratory fungal infection. Immunity 2006; 25: 665-675.
52. Bellocchio S, Montagnoli C, Bozza S, et al. The contribution of the Toll-Like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens In Vivo. J Immunol 2004; 172: 3059-3069.
53. De Luca A, Montagnoli C, Zelante T, et al. Functional yet balanced reactivity to Candida albicans requires TRIF, MyD88, and IDO-dependent inhibition of Rorc. J Immunol 2007; 179: 5999-6008.
54. Hogaboam CM, Carpenter KJ, Schuh JM, Buckland KF. Aspergillus and asthma - any link? Med Mycol 2005; 43(Suppl. 1): S197-202.
55. Gordon S. Pattern recognition receptors: Doubling up for the innate immune response. Cell 2002; 111: 927-930.
56. Coughlin SR, Camerer E. PARticipation in inflammation. J Clin Invest 2003; 111: 25-27.
57. Kauffman HF, Tomee JF, van de Riet MA, Timmerman AJ, Borger P. Protease-dependent activation of epithelial cells by fungal allergens leads to morphologic changes and cytokine production. J Allergy Clin Immunol 2000; 105: 1185-1193.
58. Ossovskaya VS, Bunnett NW. Protease-activated receptors: Contribution to physiology and disease. Physiol Rev 2004; 84: 579-621.
59. Lopes Bezerra LM, Filler SG. Interactions of Aspergillus fumigatus with endothelial cells: Internalization, injury, and stimulation of tissue factor activity. Blood 2004; 103: 2143-2149.
60. Moretti S, Bellocchio S, Bonifazi P, et al. The contribution of PARs to inflammation and immunity to fungi. Mucosal Immunology 2008; 1: 156-168.
61. Matzinger P. The danger model: A renewed sense of self. Science 2002; 296: 301-305.
62. Coaker G, Falick A, Staskawicz B. Activation of a phytopathogenic bacterial effector protein by a eukaryotic cyclophilin. Science 2005; 308: 548-550.
63. Rooney HC, Van't Klooster JW, van der Hoorn RA, et al. Cladosporium Avr2 inhibits tomato Rcr3 protease required for Cf- 2-dependent disease resistance. Science 2005; 308: 1783-1786.
64. Ferrandon D, Imler JL, Hetru C, Hoffmann JA. The Drosophila systemic immune response: Sensing and signalling during bacterial and fungal infections. Nat Rev Immunol 2007; 7: 862-874.
65. Kopp E, Ghosh S. Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 1994; 265: 956-959.
66. Shuto T, Imasato A, Jono H, et al. Glucocorticoids synergistically enhance nontypeable Haemophilus influenzae-induced Toll-like receptor 2 expression via a negative cross-talk with p38 MAP kinase. J Biol Chem 2002; 277: 17263-17270.
67. Fiorucci S, Mencarelli A, Palazzetti B, et al. Proteinase-activated receptor 2 is an anti-inflammatory signal for colonic lamina propria lymphocytes in a mouse model of colitis. Proc Natl Acad Sci USA 2001; 98: 13936-13941.
68. O'Neill LA. Therapeutic targeting of Toll-like receptors for inflammatory and infectious diseases. Curr Opin Pharmacol 2003; 3: 396-403.